Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy

by Seyed Moein Moghimi, Fatemeh Rahbarizadeh, Davoud Ahmadvand, Ladan Parhamifar
Published 2013-01-01

Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytes

by Seyed Reza Banihahsemi, Ahmad Zavaran Hosseini, Fatemeh Rahbarizadeh, Davoud Ahmadvand
Published 2018-05-01

A VHH-Based Anti-MUC1 Chimeric Antigen Receptor For Specific Retargeting Of Human Primary T Cells To MUC1-Positive Cancer Cells

by Alireza Rajabzadeh, Fatemeh Rahbarizadeh, Davoud Ahmadvand, Maryam Kabir Salmani, Amir Ali Hamidieh
Published 2021-01-01

Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide

by Lin-Ping Wu, Davoud Ahmadvand, Junan Su, Arnaldur Hall, Xiaolong Tan, Z. Shadi Farhangrazi, S. Moein Moghimi
Published 2019-10-01